Extinction and reinstatement to cocaine-associated cues in male and female juvenile rats and the role of D1 dopamine receptor.
Extinction of behaviors in response to drug-associated cues and prevention of reinstatement are integral for addiction treatment, and can reverse or ameliorate the harmful consequences of drug use. The mechanisms controlling extinction and reinstatement involve prefrontal cortical dopamine receptors, which change in expression and activity during the juvenile and adolescent transitions until they mature in adulthood. Little is known about the role that PFC D1 dopamine receptors play in extinction of drug-paired associations early in life. We used extinction of place preferences for cocaine in juvenile male and female rats following genetic, cell-specific overexpression of D1 on glutamatergic cells in the PFC. All subjects needed to demonstrate cocaine preferences for inclusion in the extinction studies. Here, male juveniles with a preference to 10 mg/kg cocaine took longer to extinguish preferences compared to both male adults and female juveniles. Female juveniles extinguished more rapidly than male juveniles at 20 mg/kg cocaine. Overexpression of D1 in juvenile males significantly facilitated extinction relative to juvenile male controls, whereas D1 prolonged expression of extinction in adults overexpressing D1 and adolescents who naturally have elevated D1 expression. These data suggest that an immature D1 profile in juveniles prevented the learning of new associations, and D1 overexpression may provide sufficient activity to facilitate extinction learning. D1 overexpression reduced reinstatement to a priming dose of cocaine in juvenile males. Together, these data show D1 expression may re-program motivational circuitry to facilitate extinction learning during juvenility that is normally unavailable to juveniles and that sex differences exist.
Laboratory for Developmental Neuropharmacology, McLean Hospital, 115 Mill St, Belmont, MA 02478, USA. Electronic address: hbrenhouse@neu.edu.
Heather C
HC
Brenhouse
Laboratory for Developmental Neuropharmacology, McLean Hospital, 115 Mill St, Belmont, MA 02478, USA.
Britta S
BS
Thompson
Harvard Medical School, 115 Mill St, Belmont, MA 02478, USA.
Kai C
KC
Sonntag
Laboratory for Developmental Neuropharmacology, McLean Hospital, 115 Mill St, Belmont, MA 02478, USA. Electronic address: sandersen@mclean.harvard.edu.
Susan L
SL
Andersen
D000818:Animals; D016739:Behavior, Addictive / Q000503:physiopathology; D003042:Cocaine / Q000494:pharmacology*; D019970:Cocaine-Related Disorders / Q000503:physiopathology*; D003213:Conditioning, Psychological / Q000187:drug effects* / Q000502:physiology; D003463:Cues; D018765:Dopamine Uptake Inhibitors / Q000494:pharmacology*; D005108:Extinction, Psychological / Q000187:drug effects* / Q000502:physiology; D005260:Female; D018698:Glutamic Acid / Q000378:metabolism; D008297:Male; D009474:Neurons / Q000187:drug effects / Q000502:physiology; D017397:Prefrontal Cortex / Q000187:drug effects / Q000254:growth & development / Q000503:physiopathology; D017207:Rats, Sprague-Dawley; D017447:Receptors, Dopamine D1 / Q000378:metabolism*; D060865:Repetition Priming / Q000187:drug effects / Q000502:physiology; D012727:Sex Characteristics; D013037:Spatial Behavior / Q000187:drug effects / Q000502:physiology
D018765:Dopamine Uptake Inhibitors; D017447:Receptors, Dopamine D1; D018698:Glutamic Acid; D003042:Cocaine
Adolescence; Cocaine; D1; Extinction; Reinstatement